Tag: "announced" at medical news

Surgeon General at Children's Hospital & Research Center at Oakland

... U.S. Surgeon General Richard H. Carmona recently announced his Year of the Healthy Child agenda, which focuses on improving the body, mind and spirit of growing children WHY: The U.S. Surgeon General was invited to Children's Hospital & Research Center at Oakland to share his vision of health care for the ...

'EuroVacc 02' HIV vaccine trial begins in February 2005

...he European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevale...

Johns Hopkins scientists receive presidential medals

...tates' top scientific recognition, the White House announced today. The two will be the seventh and eighth Johns Hopkins faculty members to receive this honor. Giacconi and Snyder will receive the medals in a White House ceremony on Monday, March 14. "Sol's and Riccardo's careers -- as scientists and as leade...

NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks

...e of Allergy and Infectious Diseases (NIAID) today announced that it is soliciting applications from U.S. and overseas research institutions seeking to become Clinical Trials Units (CTUs) in the Institute's revamped HIV/AIDS Clinical Trials Networks. NIAID, part of the U.S. National Institutes of Health (NIH),...

Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program

Northwestern Memorial Hospital today announced that Neil G. Bluhm, a prominent real estate developer, and his family have committed $10 million to the Northwestern Cardiovascular Institute, which has been renamed the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital. The Bluhm Car...

Leadership gift from Sulpizio Family for new state-of-the-art cardiovascular center at UCSD

The University of California, San Diego today announced a leadership gift of $10 million from Richard and Maria (Gaby) Sulpizio, to support the construction of a new state-of-the-art facility that will centralize UCSD's cutting-edge patient care and clinical research activities in heart and vascular disea...

ASGE announces grant recipients in annual research awards program

...ntestinal Endoscopy (ASGE) and the ASGE Foundation announced this year's institutional winners of medical research grants, as part of the ASGE's annual Research & Outcomes & Effectiveness Awards Program. The ASGE Research Committee received 31 applications for research project funding last fall and granted a t...

UC Irvine's undergraduate research programs receive $900,000 funding boost

...75,000 grant from the National Science Foundation, announced this month, will establish a Research Experience for Undergraduates site in integrated micro/nanosystems -- a program beginning this summer that will allow students from colleges across the country to conduct research at UCI for 10 weeks. Beginning t...

Olson family donates $1 million to Arizona Cancer Center

Arizona head men's basketball coach Lute Olson announced Monday that he and his family will be making a $1 million gift to the Arizona Cancer Center at the University of Arizona. The gift from the entire Olson family will benefit the Bobbi Olson Endowment for Ovarian Cancer Research. The endowment was esta...

Cogtest and NetMet join forces

...lc, with offices in London, Chicago and New Delhi, announced today a collaborative agreement whereby the clinical facilities, trial site networks, proprietary technologies and scientific expertise of each company would be made available to the other. The clinical facilities of the two companies stretch across...

First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)

NEW YORK, Jan. 11--Forest Laboratories, Inc. announced today that Campral(R) (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide. Campral was approved by the U.S. Food and Drug Administration (FDA) on July 29, 2004 for the maintenance of abst...

RelayHealth selected by Columbia University to link doctors and patients online

...nline doctor-patient communication services, today announced a three-year licensing agreement with CPPN the phy...ebVisits®, as part of a pilot program recently announced by Empire Blue Cross Blue Shield, the largest health insurer in New York State, according to HMO and...

Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers

Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRS TM clinical trial from eight to 40 medical centers nationwide, accelerating the trial's recruitment and enrollment efforts. The Cancion CRS therapy is a percutan...

New 'ITN Scholars Program' provides junior faculty opportunity to develop clinical trials expertise

The Immune Tolerance Network (ITN) has announced a new clinical research fellowship program that will provide promising junior-level faculty with intensive, hands-on training in the planning, design and implementation of clinical trials. The "ITN Scholars Program" aims to begin addressing the need ...

Society of Hospital Medicine selects John Wiley & Sons, Inc. to publish The Hospitalist Newsletter

The Society of Hospital Medicine (SHM) has announced a new publishing agreement whereby global publishe...addition to the agreement with Wiley, SHM has also announced that Pharmaceutical Media Inc. (PMI) will provide full-service advertising sales support for The Hos...

Pfizer's antifungal medicine VFEND receives FDA approval

NEW YORK, December 28, 2004 Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved the use of its extended-spectrum antifungal VFEND (voriconazole; IV for injection, tablets, and oral suspension) for the treatment of candidemia in nonneutropenic patients (those without...

FDA approves Enablex for treatment of overactive bladder

..., 2004 Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency. Enablex, a...

Novartis announces collaboration with Bayer for EMSELEX

Basel, 17 December 2004 Novartis Pharma AG announced today the start of a collaboration between Novartis Pharma GmbH and Bayer Vital AG for the commercialization and distribution of EMSELEX (darifenacin hydrobromide), 7.5 mg and 15 mg in Germany. The collaboration is effective following an agreement be...

Four teams awarded inaugural translational cancer research grants

...nce with The V Foundation for Cancer Research, has announced the first-ever recipients of The V Foundation-AACR Grants in Translational Cancer Research. Four teams of cancer researchers two from Virginia and one each from Ohio and Massachusetts are receiving combined support from both organizations and their...

NIH halts use of COX-2 inhibitor in large cancer prevention trial

The National Institutes of Health (NIH) announced today that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI). The study, called the Adenoma Preve...

1 2 3 4 5 6 7 8 9 10

(Date:11/24/2014)... York (PRWEB) November 24, 2014 The ... by the Family and Children's Association to ... as soap, shampoo, mouthwash and other such items.The Association's ... who are home bound, living in nursing homes, assisted ... to greatly enhance the well being of seniors throughout ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 The typical ... of the wrong ingredients. Consistently consuming a diet high ... develop stores of excess fat that typically accumulate around ... and rearing its ugly head in the form of ... When dieters make the decision to rid themselves of ...
(Date:11/24/2014)... Gersowitz Libo & Korek, P.C., a leading ... Tier recognition in the 2015 Edition of U.S. News-Best Lawyers ... a unique combination of quality law practice and breadth of ... honor and especially grateful to our clients whose continued support ... possible,” said Jeff S. Korek, senior partner at Gersowitz ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
(Date:11/23/2014)... 23, 2014 The report, “Market ... to 2020 - Asia-Pacific” provides quantitative analysis of ... segments: minimally invasive body contouring devices, non-invasive body ... includes market size data by revenue and volume ... countries: China, Japan, South Korea, Australia and India. ...
Breaking Medicine News(10 mins):Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4
Other Tags
papilloncapturedntildeintratumoralphilipsepsrcingenuityniozobtainingsystemsphysiologicalrandomflowsexpressionallomapxdx